NME1

Nucleoside diphosphate kinase A · P15531 · NME1 on Sugi Atlas →

0 patent compounds predicted against NME1, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to NME1 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Acelarin First Line Randomised Pancreatic Study PHASE2/PHASE3SUSPENDED
Letrozole After Tamoxifen in Treating Women With Breast Cancer PHASE3COMPLETED
Effects of Vitamin B3 in Patients With Ataxia Telangiectasia PHASE2COMPLETED
Study of Gemcitabine, Carboplatin and VELIPARIB (ABT-888) in Refractory Testicular Germ Cell Cancer PHASE2COMPLETED
A Phase 1/2 Study of Safety and Tolerability of MT-125 With Chemoradiation in Patients With Newly Diagnosed MGMT Methylated Glioblastoma PHASE1/PHASE2NOT_YET_RECRUITING
A Study of Sorafenib in Patients With Chemonaive Metastatic Uveal Melanoma PHASE2UNKNOWN
Combination Chemotherapy, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer PHASE2COMPLETED
Study of Sorafenib and Docetaxel in Metastatic Prostate Cancer PHASE2COMPLETED
A Phase 1/2 Study of the Safety and Tolerability of MT-125 in GBM Patients PHASE1/PHASE2RECRUITING
Induction Erlotinib Therapy in Stage III A (N2) Non-Small Cell Lung Cancer (NSCLC) PHASE2COMPLETED
Phase II Study of Simvastatin Plus Irinotecan, Fluorouracil, and Leucovorin(FOLFIRI) for Metastatic CRC PHASE2COMPLETED
Phase 1a Single Ascending Dose Study of MIB-725 in Healthy Adults PHASE1RECRUITING
Intravenous Immune Globulin to Treat Hereditary Inclusion Body Myopathy PHASE1COMPLETED
Nucleoside Therapy in Patients With Telomere Biology Disorders PHASE1RECRUITING
Phase I Trial of Bevacizumab and Temsirolimus in Combination With 1) Carboplatin, 2) Paclitaxel, 3) Sorafenib for the Treatment of Advanced Cancer PHASE1ACTIVE_NOT_RECRUITING
A Randomized Controlled Trial of Topical 5% Niacinamide for Skin Cancer Prevention in Transplant Recipients EARLY_PHASE1RECRUITING
Investigate eNAMPT in Multiple Myeloma Biology and Establish Its Role in Disease Progression nanCOMPLETED
Ataxia-telangiectasia: Treating Mitochondrial Dysfunction With Nicotinamide Riboside nanUNKNOWN
The Roles of Neutrophil Elastase in Lung Cancer nanUNKNOWN
Genetic Analysis of Familial Melanoma nanCOMPLETED
Genetics of Neonatal Encephalopathy and Related Disorders nanRECRUITING
Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients nanRECRUITING
Study of the Genetic and Epigenetic Causes of Recurrent Hydatidiform Moles nanACTIVE_NOT_RECRUITING
Natural History Study for Patients With Nemaline Myopathy in Spain nanRECRUITING
DNA Adductomics for Colorectal Cancer Investigation nanUNKNOWN
Whole Exome and Whole Genome Sequencing for Genotyping of Inherited and Congenital Eye Conditions nanRECRUITING
Natural History of Apparent Mineralocorticoid Excess Syndrome nanCOMPLETED
Quantitative Assessment of the Etiologies of Megalencephaly Associated With a Detectable Tumor Risk nanNOT_YET_RECRUITING
Study of the Effect of Innate on the Inflammatory Response to Endotoxin nanRECRUITING
Cyclosporin A Therapy in Childhood Nephrotic Syndrome nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a NME1 binder may also engage these)

ProteinNameSimilarity
P19804 1.000 P19804 →
Q5RC56 1.000 Q5RC56 →
P52174 1.000 P52174 →
P70010 1.000 P70010 →
Q50KA9 1.000 Q50KA9 →
Q6HL40 1.000 Q6HL40 →
Q2EN76 0.999 Q2EN76 →
Q8TFN0 0.998 Q8TFN0 →
P50590 0.998 P50590 →
P27950 0.998 P27950 →
Q3AFJ7 0.998 Q3AFJ7 →
Q5RFH3 0.998 Q5RFH3 →
O57535 0.997 O57535 →
Q7V3M8 0.997 Q7V3M8 →
Q3ZZF6 0.997 Q3ZZF6 →
O84508 0.997 O84508 →
P52175 0.997 P52175 →
Q5KXU2 0.997 Q5KXU2 →
Q90380 0.997 Q90380 →
Q2FGX3 0.997 Q2FGX3 →
A7X2H3 0.997 A7X2H3 →
Q01768 0.997 Q01768 →
Q39839 0.997 Q39839 →
P70011 0.997 P70011 →
A2STK8 0.997 A2STK8 →
Q3T0Q4 0.997 Q3T0Q4 →
Q05982 0.997 Q05982 →
B1WQB7 0.997 B1WQB7 →
B9KSS4 0.996 B9KSS4 →
B7VJT4 0.996 B7VJT4 →